2-for-1 biomarker and tumor suppressor; Biomarkers for early-stage Parkinson's;

> Researchers at the University of California, San Diego School of Medicine have found a possible two-for-one deal: an antibody that can be used as a biomarker for cancer risk and also a treatment for suppressing tumor growth. UC San Diego news release

> Activation of biomarker linked with improved survival among obese patients with colorectal cancer. More here

> Scientists detect several biomarkers to screen active drugs for Batten disease, a rare disease that begins in childhood with visual impairment and ends in failure of all motor abilities. Item

> Biomarkers for detecting the early stages of Parkinson's disease could accelerate development of new treatments. Abstract

> GVK Biosciences, an Indian contract research organization, has extended its agreement with the Food and Drug Administration for the U.S. agency to access its biomarker database. The FDA uses the the information to develop its guidance on biomarker qualification. Item

> The Wisconsin Alumni Research Foundation is seeking commercial partners interested in developing genes that could be used as biomarkers for prostate cancer screening. Details

> Proteins in leaked amniotic fluid could be used as biomarkers for prelabor rupture of membranes. Abstract

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.